Calleja Gregorio A MD is categorized under Family Practice Doctors in Rockaway Park, NY and active since 1982.
Calleja Gregorio A MD was established in 1982, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Gregorio Calleja at the company’s single location by writing to 10710 Shore Front Parkway # 1, Rockaway Park, New York NY 11694 or by phoning (718) 474-2656. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Calleja Gregorio A MD |
| Contact Person: | Gregorio Calleja |
| Address: | 10710 Shore Front Parkway # 1, Rockaway Park, New York 11694 |
| Phone Number: | (718) 474-2656 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Calleja Gregorio A MD was started in 1982 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Gregorio Calleja for inquiries that concern Calleja Gregorio A MD by calling the company number (718) 474-2656, as your correspondence is most welcome. Additionally, the physical location of the single location of Calleja Gregorio A MD can be found at the coordinates 40.580774,-73.827221 as well as the street address 10710 Shore Front Parkway # 1 in Rockaway Park, New York 11694.
For its online presence, you may visit Calleja Gregorio A MD’s website at and engage with its social media outlets through on Twitter and on Facebook.